(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE

Star0

DB08073ExperimentalSmall molecule

(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE: Overview.

Formula / weight: C₂₄H₂₃N₅O · 397.4723 g/mol (avg)

Resolves to

Compound

UNIIQ4UG565ZYHChEMBLCHEMBL379300ChEBI91351PubChem10172943

Structure

InChIKeyYWTBGJGMTBHQTM-IBGZPJMESA-NSMILES[H][C@@](N)(COC1=CN=CC(=C1)C1=CC=C2NN=C(C)C2=C1)CC1=CNC2=CC=CC=C12

Targets

P31749AKT1P31751AKT2P49841GSK3BP17612PRKACAP61925PKIA

What you can answer from here — as of April 02, 2025

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account